Skip to main content
SpringerLink
Log in

Microbial Dysbiosis in Oral Cancer

  • Chapter
  • First Online:
Microbes and Oral Squamous Cell Carcinoma

  • 305 Accesses

Abstract

Dysbiosis has been proposed to be one of the multiple etiological factors in development and progression of many cancers. Tobacco, alcohol, and betel nut are the common causative factors of oral cancer, which might also lead to the alteration of the oral microbiome composition. Based on knowledge of the carcinogenic effects of dysbiosis, it was recently suggested that probiotics may have antitumor activity. This chapter reviews the role of microbial dysbiosis in oral cancer pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Seymour GJ, Ford PJ, Cullinan MP, Leishman S, Yamazaki K (2007) Relationship between periodontal infections and systemic disease. Clin Microbiol Infect 13(Suppl 4):3–10

    Article  CAS  PubMed  Google Scholar 

  2. Beck JD, Offenbacher S (2005) Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. J Periodontol 76(Suppl 11S):2089–2100

    Article  PubMed  Google Scholar 

  3. Joshipura KJ, Rimm EB, Douglass CW, Trichopoulos D, Ascherio A, Willett WC (1996) Poor oral health and coronary heart disease. J Dent Res 75(9):1631–1636

    Article  CAS  PubMed  Google Scholar 

  4. Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y (2005) A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J Periodontol 76(11 Suppl):2075–2084

    Article  PubMed  Google Scholar 

  5. Joshipura KJ, Hung HC, Rimm EB, Willett WC, Ascherio A (2003) Periodontal disease, tooth loss, and incidence of ischemic stroke. Stroke 34(1):47–52

    Article  PubMed  Google Scholar 

  6. Offenbacher S, Jared HL, O’Reilly PG, Wells SR, Salvi GE, Lawrence HP et al (1998) Potential pathogenic mechanisms of periodontitis associated pregnancy complications. Ann Periodontol 3(1):233–250

    Article  CAS  PubMed  Google Scholar 

  7. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE (2005) Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 43(11):5721–5732

    Article  PubMed  PubMed Central  Google Scholar 

  8. Duran-Pinedo AE, Frias-Lopez J (2015) Beyond microbial community composition: functional activities of the oral microbiome in health and disease. Microbes Infect 17(7):505–516

    Article  PubMed  PubMed Central  Google Scholar 

  9. Costalonga M, Herzberg MC (2014) The oral microbiome and the immunobiology of periodontal disease and caries. Immunol Lett 162(2 Pt A):22–38

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Griffen AL, Beall CJ, Campbell JH, Firestone ND, Kumar PS, Yang ZK et al (2012) Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J 6(6):1176–1185

    Article  CAS  PubMed  Google Scholar 

  11. Haubek D (2010) The highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans: evolutionary aspects, epidemiology and etiological role in aggressive periodontitis. APMIS Suppl (130):1–53

    Google Scholar 

  12. Jorth P, Turner KH, Gumus P, Nizam N, Buduneli N, Whiteley M (2014) Metatranscriptomics of the human oral microbiome during health and disease. MBio 5(2):e01012–e01014

    Article  PubMed  PubMed Central  Google Scholar 

  13. Liu S, Zhou X, Peng X, Li M, Ren B, Cheng G et al (2020) Porphyromonas gingivalis promotes immunoevasion of oral cancer by protecting cancer from macrophage attack. J Immunol 205(1):282–289

    Article  CAS  PubMed  Google Scholar 

  14. Vartoukian SR, Palmer RM, Wade WG (2009) Diversity and morphology of members of the phylum “synergistetes” in periodontal health and disease. Appl Environ Microbiol 75(11):3777–3786

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Koo H, Bowen WH (2014) Candida albicans and Streptococcus mutans: a potential synergistic alliance to cause virulent tooth decay in children. Future Microbiol 9(12):1295–1297

    Article  CAS  PubMed  Google Scholar 

  16. Willis JR, Gabaldon T (2020) The human oral microbiome in health and disease: from sequences to ecosystems. Microorganisms 8(2)

    Google Scholar 

  17. Whiley RA, Fleming EV, Makhija R, Waite RD (2015) Environment and colonisation sequence are key parameters driving cooperation and competition between Pseudomonas aeruginosa cystic fibrosis strains and oral commensal streptococci. PLoS One 10(2):e0115513

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Chhibber-Goel J, Singhal V, Bhowmik D, Vivek R, Parakh N, Bhargava B et al (2016) Linkages between oral commensal bacteria and atherosclerotic plaques in coronary artery disease patients. NPJ Biofilm Microbiom 2:7

    Article  Google Scholar 

  19. Teles R, Wang CY (2011) Mechanisms involved in the association between periodontal diseases and cardiovascular disease. Oral Dis 17(5):450–461

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Roszyk E, Puszczewicz M (2017) Role of human microbiome and selected bacterial infections in the pathogenesis of rheumatoid arthritis. Reumatologia 55(5):242–250

    Article  PubMed  PubMed Central  Google Scholar 

  21. Scher JU, Ubeda C, Equinda M, Khanin R, Buischi Y, Viale A et al (2012) Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum 64(10):3083–3094

    Article  PubMed  PubMed Central  Google Scholar 

  22. Aguayo S, Schuh C, Vicente B, Aguayo LG (2018) Association between Alzheimer’s disease and oral and gut microbiota: are pore forming proteins the missing link? J Alzheimer’s Dis 65(1):29–46

    Article  Google Scholar 

  23. Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A et al (2019) Porphyromonas gingivalis in Alzheimer’s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv 5(1):eaau3333

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Miklossy J (2016) Bacterial amyloid and DNA are important constituents of senile plaques: further evidence of the spirochetal and biofilm nature of senile plaques. J Alzheimer’s Dis 53(4):1459–1473

    Article  CAS  Google Scholar 

  25. Casarin RC, Barbagallo A, Meulman T, Santos VR, Sallum EA, Nociti FH et al (2013) Subgingival biodiversity in subjects with uncontrolled type-2 diabetes and chronic periodontitis. J Periodontal Res 48(1):30–36

    Article  CAS  PubMed  Google Scholar 

  26. Imawana RA, Smith DR, Goodson ML (2020) The relationship between inflammatory bowel disease and Helicobacter pylori across East Asian, European and Mediterranean countries: a meta-analysis. Ann Gastroenterol 33(5):485–494

    PubMed  PubMed Central  Google Scholar 

  27. Avila M, Ojcius DM, Yilmaz O (2009) The oral microbiota: living with a permanent guest. DNA Cell Biol 28(8):405–411

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Dovrolis N, Kolios G, Spyrou GM, Maroulakou I (2019) Computational profiling of the gut-brain axis: microflora dysbiosis insights to neurological disorders. Brief Bioinform 20(3):825–841

    Article  CAS  PubMed  Google Scholar 

  29. Zhang WL, Wang SS, Wang HF, Tang YJ, Tang YL, Liang XH (2019) Who is who in oral cancer? Exp Cell Res 384(2):111634

    Article  CAS  PubMed  Google Scholar 

  30. Radaic A, Kapila YL (2021) The oralome and its dysbiosis: new insights into oral microbiome-host interactions. Comput Struct Biotechnol J 19:1335–1360

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Petersen C, Round JL (2014) Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol 16(7):1024–1033

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Pang X, Tang YJ, Ren XH, Chen QM, Tang YL, Liang XH (2018) Microbiota, epithelium, inflammation, and TGF-beta signaling: an intricate interaction in oncogenesis. Front Microbiol 9:1353

    Article  PubMed  PubMed Central  Google Scholar 

  33. Gomar-Vercher S, Cabrera-Rubio R, Mira A, Montiel-Company JM, Almerich-Silla JM (2014) Relationship of children’s salivary microbiota with their caries status: a pyrosequencing study. Clin Oral Investig 18(9):2087–2094

    Article  CAS  PubMed  Google Scholar 

  34. Lamont RJ, Koo H, Hajishengallis G (2018) The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol 16(12):745–759

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Tonoyan L, Vincent-Bugnas S, Olivieri CV, Doglio A (2019) New viral facets in oral diseases: the EBV paradox. Int J Mol Sci 20(23):5861

    Article  CAS  PubMed Central  Google Scholar 

  36. Dolcet X, Llobet D, Pallares J, Matias-Guiu X (2005) NF-kB in development and progression of human cancer. Virchows Arch 446(5):475–482

    Article  CAS  PubMed  Google Scholar 

  37. Guarneri C, Bevelacqua V, Polesel J, Falzone L, Cannavo PS, Spandidos DA et al (2017) NFkappaB inhibition is associated with OPN/MMP9 downregulation in cutaneous melanoma. Oncol Rep 37(2):737–746

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Leonardi GC, Falzone L, Salemi R, Zanghi A, Spandidos DA, McCubrey JA et al (2018) Cutaneous melanoma: from pathogenesis to therapy (review). Int J Oncol 52(4):1071–1080

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Couturier-Maillard A, Secher T, Rehman A, Normand S, De Arcangelis A, Haesler R et al (2013) NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest 123(2):700–711

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Francescone R, Hou V, Grivennikov SI (2014) Microbiome, inflammation, and cancer. Cancer J 20(3):181–189

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Hu B, Elinav E, Huber S, Strowig T, Hao L, Hafemann A et al (2013) Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc Natl Acad Sci U S A 110(24):9862–9867

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. La Rosa GRM, Gattuso G, Pedulla E, Rapisarda E, Nicolosi D, Salmeri M (2020) Association of oral dysbiosis with oral cancer development. Oncol Lett 19(4):3045–3058

    PubMed  PubMed Central  Google Scholar 

  43. Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ et al (2014) Landscape of genomic alterations in cervical carcinomas. Nature 506(7488):371–375

    Article  CAS  PubMed  Google Scholar 

  44. Sharon G, Garg N, Debelius J, Knight R, Dorrestein PC, Mazmanian SK (2014) Specialized metabolites from the microbiome in health and disease. Cell Metab 20(5):719–730

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Basic A, Blomqvist S, Carlen A, Dahlen G (2015) Estimation of bacterial hydrogen sulfide production in vitro. J Oral Microbiol 7:28166

    Article  PubMed  Google Scholar 

  46. Hezel MP, Weitzberg E (2015) The oral microbiome and nitric oxide homoeostasis. Oral Dis 21(1):7–16

    Article  CAS  PubMed  Google Scholar 

  47. Whitmore SE, Lamont RJ (2014) Oral bacteria and cancer. PLoS Pathog 10(3):e1003933

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  48. Kato I, Vasquez AA, Moyerbrailean G, Land S, Sun J, Lin HS et al (2016) Oral microbiome and history of smoking and colorectal cancer. J Epidemiol Res 2(2):92–101

    Article  PubMed  PubMed Central  Google Scholar 

  49. Fan X, Alekseyenko AV, Wu J, Peters BA, Jacobs EJ, Gapstur SM et al (2018) Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut 67(1):120–127

    Article  CAS  PubMed  Google Scholar 

  50. Torres PJ, Fletcher EM, Gibbons SM, Bouvet M, Doran KS, Kelley ST (2015) Characterization of the salivary microbiome in patients with pancreatic cancer. PeerJ 3:e1373

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  51. Kim SS, Ruiz VE, Carroll JD, Moss SF (2011) Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Lett 305(2):228–238

    Article  CAS  PubMed  Google Scholar 

  52. Nagaraja V, Eslick GD (2014) Systematic review with meta-analysis: the relationship between chronic Salmonella typhi carrier status and gall-bladder cancer. Aliment Pharmacol Ther 39(8):745–750

    Article  CAS  PubMed  Google Scholar 

  53. Toprak NU, Yagci A, Gulluoglu BM, Akin ML, Demirkalem P, Celenk T et al (2006) A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect 12(8):782–786

    Article  CAS  PubMed  Google Scholar 

  54. Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM (2005) The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med 3:27

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Pushalkar S, Ji X, Li Y, Estilo C, Yegnanarayana R, Singh B et al (2012) Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma. BMC Microbiol 12:144

    Article  PubMed  PubMed Central  Google Scholar 

  56. Wang L, Ganly I (2014) The oral microbiome and oral cancer. Clin Lab Med 34(4):711–719

    Article  PubMed  Google Scholar 

  57. Peters BA, Wu J, Pei Z, Yang L, Purdue MP, Freedman ND et al (2017) Oral microbiome composition reflects prospective risk for esophageal cancers. Cancer Res 77(23):6777–6787

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Lafuente Ibanez de Mendoza I, Maritxalar Mendia X, Garcia de la Fuente AM, Quindos Andres G, Aguirre Urizar JM (2020) Role of Porphyromonas gingivalis in oral squamous cell carcinoma development: a systematic review. J Periodontal Res 55(1):13–22

    Article  PubMed  Google Scholar 

  59. Chang C, Geng F, Shi X, Li Y, Zhang X, Zhao X et al (2019) The prevalence rate of periodontal pathogens and its association with oral squamous cell carcinoma. Appl Microbiol Biotechnol 103(3):1393–1404

    Article  CAS  PubMed  Google Scholar 

  60. Kuboniwa M, Hasegawa Y, Mao S, Shizukuishi S, Amano A, Lamont RJ et al (2008) P. gingivalis accelerates gingival epithelial cell progression through the cell cycle. Microbes Infect 10(2):122–128

    Article  CAS  PubMed  Google Scholar 

  61. Hoppe T, Kraus D, Novak N, Probstmeier R, Frentzen M, Wenghoefer M et al (2016) Oral pathogens change proliferation properties of oral tumor cells by affecting gene expression of human defensins. Tumour Biol 37(10):13789–13798

    Article  CAS  PubMed  Google Scholar 

  62. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM et al (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258(5089):1798–1801

    Article  CAS  PubMed  Google Scholar 

  63. Geginat J, Larghi P, Paroni M, Nizzoli G, Penatti A, Pagani M et al (2016) The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer. Cytokine Growth Factor Rev 30:87–93

    Article  CAS  PubMed  Google Scholar 

  64. Schadendorf D, Moller A, Algermissen B, Worm M, Sticherling M, Czarnetzki BM (1993) IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 151(5):2667–2675

    CAS  PubMed  Google Scholar 

  65. Singh RK, Gutman M, Reich R, Bar-Eli M (1995) Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. Cancer Res 55(16):3669–3674

    CAS  PubMed  Google Scholar 

  66. Ginestier C, Liu S, Diebel ME, Korkaya H, Luo M, Brown M et al (2010) CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 120(2):485–497

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Khan MN, Wang B, Wei J, Zhang Y, Li Q, Luan X et al (2015) CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis. Oncotarget 6(25):21315–21327

    Article  PubMed  PubMed Central  Google Scholar 

  68. Lo MC, Yip TC, Ngan KC, Cheng WW, Law CK, Chan PS et al (2013) Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres. Cancer Lett 335(1):81–92

    Article  CAS  PubMed  Google Scholar 

  69. Harrandah AM, Chukkapalli SS, Bhattacharyya I, Progulske-Fox A, Chan EKL (2020) Fusobacteria modulate oral carcinogenesis and promote cancer progression. J Oral Microbiol 13(1):1849493

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  70. Liu B, Faller LL, Klitgord N, Mazumdar V, Ghodsi M, Sommer DD et al (2012) Deep sequencing of the oral microbiome reveals signatures of periodontal disease. PLoS One 7(6):e37919

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M et al (2013) Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14(2):207–215

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Life Science, Bhubaneswar, Odisha, India

    Shaheerah Khan & Anshuman Dixit

  2. University of Nebraska-Lincoln, Lincoln, NE, USA

    Rohita Sinha

  3. Department of ENT, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India

    Saurav Sarkar

  4. Department of Dentistry, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India

    Samapika Routray

Authors
  1. Shaheerah Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rohita Sinha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Saurav Sarkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anshuman Dixit
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Samapika Routray
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Samapika Routray .

Editor information

Editors and Affiliations

  1. Department of Dentistry, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India

    Samapika Routray

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Khan, S., Sinha, R., Sarkar, S., Dixit, A., Routray, S. (2022). Microbial Dysbiosis in Oral Cancer. In: Routray, S. (eds) Microbes and Oral Squamous Cell Carcinoma. Springer, Singapore. https://doi.org/10.1007/978-981-19-0592-6_8

Download citation

Publish with us

Policies and ethics

Search

Navigation